Xeris Pharmaceuticals Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke Kit for the Treatment of Severe Hypoglycemia

First ready-to-use liquid glucagon available in a single-dose vial and syringe kit for rescue Gvoke HypoPen®, Gvoke® PFS, and Gvoke® Kit– three different administration options to accommodate patients’ preferences Gvoke...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news